Sustainable Use of a Real-Time Continuous Glucose Monitoring System from 2018 to 2020

被引：13

作者：

van der Linden, Joost ^{[1
]}

Welsh, John B. ^{[2
]}

Walker, Tomas C. ^{[2
]}

机构：

[1] Dexcom Inc, Data Sci, San Diego, CA 92121 USA

[2] Dexcom Inc, Global Clin Initiat, San Diego, CA 92121 USA

来源：

DIABETES TECHNOLOGY & THERAPEUTICS | 2021年 / 23卷 / 07期

关键词：

Adherence; Calibrations; Continuous glucose monitoring; Glycemic control; Real-world data;

D O I：

10.1089/dia.2021.0014

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We aimed to describe patterns of continuous glucose monitoring (CGM) system use and glycemic outcomes from 2018 to 2020 in a large real-world cohort by analyzing anonymized data from US-based CGM users who transitioned from the G5 to the G6 System (Dexcom) in 2018. The main end points were persistent use, within-day and between-day utilization, hypoglycemia, time in range (TIR, 70-180 mg/dL [3.9-10 mmol/L]), and use of the optional calibration feature in 2019 and 2020. In a cohort of 31,034 individuals, rates of persistent use were high, with 27,932 (90.0%) and 26,861 (86.6%) continuing to upload data in 2019 and 2020, respectively. Compared with G5 use, G6 use was associated with higher device utilization, less hypoglycemia, higher TIR (in 2020), and >80% fewer calibrations in both 2019 and 2020 (P's < 0.001). High persistence and utilization of the G6 system may contribute to sustainable glycemic outcomes and decreased user burden.

引用

页码：508 / 511

页数：4

共 17 条

[1] Improved Real-World Glycemic Control With Continuous Glucose Monitoring System Predictive Alerts [J].

Abraham, Sinu Bessy ;

Arunachalam, Siddharth ;

Zhong, Alex ;

Agrawal, Pratik ;

Cohen, Ohad ;

McMahon, Chantal M. .

JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2021, 15 (01) :91-97

[2] Mitigation of Rebound Hyperglycemia With Real-Time Continuous Glucose Monitoring Data and Predictive Alerts [J].

Acciaroli, Giada ;

Welsh, John B. ;

Akturk, Halis Kaan .

JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2022, 16 (03) :677-682

[3] REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes [J].

Aleppo, Grazia ;

Ruedy, Katrina J. ;

Riddlesworth, Tonya D. ;

Kruger, Davida F. ;

Peters, Anne L. ;

Hirsch, Irl ;

Bergenstal, Richard M. ;

Toschi, Elena ;

Ahmann, Andrew J. ;

Shah, Viral N. ;

Rickels, Michael R. ;

Bode, Bruce W. ;

Philis-Tsimikas, Athena ;

Pop-Busui, Rodica ;

Rodriguez, Henry ;

Eyth, Emily ;

Bhargava, Anuj ;

Kollman, Craig ;

Beck, Roy W. .

DIABETES CARE, 2017, 40 (04) :538-545

[4] Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range [J].

Battelino, Tadej ;

Danne, Thomas ;

Bergenstal, Richard M. ;

Amiel, Stephanie A. ;

Beck, Roy ;

Biester, Torben ;

Bosi, Emanuele ;

Buckingham, Bruce A. ;

Cefalu, William T. ;

Close, Kelly L. ;

Cobelli, Claudio ;

Dassau, Eyal ;

DeVries, J. Hans ;

Donaghue, Kim C. ;

Dovc, Klemen ;

Doyle, Francis J. ;

Garg, Satish ;

Grunberger, George ;

Heller, Simon ;

Heinemann, Lutz ;

Hirsch, Irl B. ;

Hovorka, Roman ;

Jia, Weiping ;

Kordonouri, Olga ;

Kovatchev, Boris ;

Kowalski, Aaron ;

Laffel, Lori ;

Levine, Brian ;

Mayorov, Alexander ;

Mathieu, Chantal ;

Murphy, Helen R. ;

Nimri, Revital ;

Norgaard, Kirsten ;

Parkin, Christopher G. ;

Renard, Eric ;

Rodbard, David ;

Saboo, Banshi ;

Schatz, Desmond ;

Stoner, Keaton ;

Urakami, Tatsuiko ;

Weinzimer, Stuart A. ;

Phillip, Moshe .

DIABETES CARE, 2019, 42 (08) :1593-1603

[5] Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections The DIAMOND Randomized Clinical Trial [J].

Beck, Roy W. ;

Riddlesworth, Tonya ;

Ruedy, Katrina ;

Ahmann, Andrew ;

Bergenstal, Richard ;

Haller, Stacie ;

Kollman, Craig ;

Kruger, Davida ;

McGill, Janet B. ;

Polonsky, William ;

Toschi, Elena ;

Wolpert, Howard ;

Price, David .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (04) :371-378

[6]

Bergenstal Richard M, 2013, J Diabetes Sci Technol, V7, P562

[7] Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes [J].

Brown, S. A. ;

Kovatchev, B. P. ;

Raghinaru, D. ;

Lum, J. W. ;

Buckingham, B. A. ;

Kudva, Y. C. ;

Laffel, L. M. ;

Levy, C. J. ;

Pinsker, J. E. ;

Wadwa, R. P. ;

Dassau, E. ;

Doyle, F. J., III ;

Anderson, S. M. ;

Church, M. M. ;

Dadlani, V ;

Ekhlaspour, L. ;

Forlenza, G. P. ;

Isganaitis, E. ;

Lam, D. W. ;

Kollman, C. ;

Beck, R. W. .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (18) :1707-1717

[8]

Dexcom Inc, 2021, NOT PRIV PRACT YOUR

[9] State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018 [J].

Foster, Nicole C. ;

Beck, Roy W. ;

Miller, Kellee M. ;

Clements, Mark A. ;

Rickels, Michael R. ;

DiMeglio, Linda A. ;

Maahs, David M. ;

Tamborlane, William V. ;

Bergenstal, Richard ;

Smith, Elizabeth ;

Olson, Beth A. ;

Garg, Satish K. .

DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 (02) :66-72

[10] Sustained Intensive Treatment and Long-term Effects on HbA1c Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI [J].

Lind, Marcus ;

Olafsdottir, Arndis F. ;

Hirsch, Irl B. ;

Bolinder, Jan ;

Dahlqvist, Sofia ;

Pivodic, Aldina ;

Hellman, Jarl ;

Wijkman, Magnus ;

Schwarcz, Erik ;

Albrektsson, Henrik ;

Heise, Tim ;

Polonsky, William .

DIABETES CARE, 2021, 44 (01) :141-149

← 1 2 →